A 65 year old man with type 2 diabetes treated with Metformin is found to have an HbA1c of 78 mmol per mol despite good adherence and maximal tolerated Metformin. He has no history of heart failure or chronic kidney disease. What is the most appropriate next step in glycaemic management?